MedTrace Logo

CT Guided Injection for Low Back Radiculopathy: A Randomized Clinical Trial

NCT01267825 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2018-08-31

Study results available
· View outcomes & findings →

Summary

Herniated disc sometimes cause back pain radiating down to a leg. This pain can be so severe that it is functionally disabling. The purpose of this randomized clinical trial is to determine if corticosteroid medication, delivered directly to the area near the herniated disc, can improve the pain and functional disability associated with a herniated disc.

Conditions

  • Disc Herniation
  • Lumbosacral Radiculopathy

Interventions

DRUG

CT-guided corticosteroid+ bupivicaine

CT-guided corticosteroid+ bupivicaine Also get standard medical care

DRUG

Standard medical care

Naproxen + Oxycodone/ Acetaminophen

Sponsors & Collaborators

  • Montefiore Medical Center

    lead OTHER

Principal Investigators

  • Todd Miller, MD · Montefiore Medical Center

  • Benjamin W. Friedman, MD, MS · Montefiore Medical Center/Albert Einstein College of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-09-01
Primary Completion
2013-08-31
Completion
2013-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01267825 on ClinicalTrials.gov